Business Wire

NY-AB-INBEV

Share
Global Corona Brand Named Most Valuable Beer Brand in Kantar BrandZ Rankings

Today, in Kantar’s BrandZ global rankings, Corona was recognized as the most valuable beer brand in the world. Eight out of the 10 most valuable global beer brands belong to AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD), according to the report ranking the top brands in the world.

“Valued at more than $19 billion USD, Corona has become the most valuable global beer brand due to consistent acceleration of growth globally and specifically tapping into growing markets, like Brazil, China, South Africa while maintaining its stronghold in Mexico,” said Kantar CEO Chris Jansen. “Our congratulations go to the Corona team for a standout year.”

“Corona’s strength lies in how it combines emotional and functional points of difference in a unique and consistent way,” said Marcel Marcondes, AB InBev’s Global Chief Marketing Officer. “In everything that Corona does the brand evokes that emotional moment of having a break from the routine to reconnect with nature and oneself. On the functional side, consumers know that Corona is brewed with 100% natural ingredients, they love the unique, refreshing experience of the lime ritual and they appreciate that Corona is one of the first global beverage brands with a net zero plastic footprint. All these elements are why Corona is recognized as a truly premium, iconic brand anywhere in the world.”

Other AB InBev brands that made it into this year’s ranking include, Budweiser, the second most valuable beer brand in the world, Modelo at #4, Brahma at #5, Michelob Ultra at #6, Bud Light at #7, Skol at #8 and Stella Artois at #10. These brands all feature in the Top 20 Most Valuable Global Alcohol category ranking.

“Growing our megabrands is a key part of our business strategy to lead and grow the category,” said Marcondes. “Our focus is on delivering against the needs of our consumers in a way that gives them what they seek, but also in a way that earns their love.”

Published annually, the Kantar BrandZ Most Valuable Global Brands Report ranks the world’s top brands, the sector leaders, big movers and brands to watch. Providing a wealth of insights on brands, categories and marketing issues and trends over 14 years, the rankings serve as a measure of brand value and relevancy.

About AB InBev

AB InBev is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona®, Stella Artois® and Michelob Ultra®; multi-country brands Beck’s®, Hoegaarden® and Leffe®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 155,000 colleagues based in nearly 50 countries worldwide. For 2023, AB InBev’s reported revenue was 59.4 billion USD (excluding JVs and associates).

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240611731362/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Westlake Epoxy Announces Strategic Collaboration With Alpha Recyclage Composites to Advance Composites Recycling12.6.2025 08:00:00 CEST | Press release

Westlake Corporation (NYSE: WLK) announced today that Westlake Epoxy will collaborate with Alpha Recyclage Composites to support them in scaling up the recycling capacity for carbon fiber composite materials. This collaboration will provide support to Westlake’s composite customers in their development of improved circular options for both production (scrap or off spec composite materials that otherwise become waste) and end-of-life waste. The recovery of the carbon fibers from composite materials for reuse in new or emerging applications aims to establish a more sustainable alternative to traditional disposal methods such as landfilling and incineration. Alpha Recyclage Composites, a family-owned company based in Toulouse and Castelsarrasin, France, specializes in recycling carbon-fibers-reinforced composites through a patented steam pyrolysis process. This innovative technology preserves the performance qualities of the carbon fibers used in composite materials recovered from applica

Mehiläinen Yhtiöt Oy Announces Pricing of Senior Secured Notes Offering12.6.2025 08:00:00 CEST | Press release

THIS INFORMATION RELATES TO AN OFFERING OF SECURITIES OFFERED AND SOLD PURSUANT TO RULE 144A AND/OR REGULATION S (EXEMPTIONS FROM THE U.S. REGISTRATION REQUIREMENTS OF THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND IS ONLY DIRECTED AT QUALIFIED INSTITUTIONAL BUYERS UNDER RULE 144A OR OUTSIDE THE UNITED STATES OF AMERICA UNDER REGULATION S TO WHOM THE DISTRIBUTION OF THIS INFORMATION, WHETHER DIRECTLY OR INDIRECTLY, IS NOT OTHERWISE UNLAWFUL Mehiläinen Yhtiöt Oy Announces Pricing of Senior Secured Notes Offering HELSINKI, 12 June 2025 --Mehiläinen Yhtiöt Oy (the “Mehiläinen”) announced the pricing on 11 June 2025 of its offering of €350 million aggregate principal amount of its senior secured floating rate notes due 2032 (the “SSN Floating Rate Notes”) with a coupon of three-month EURIBOR, subject to a zero floor, plus 3.375% and €740 million aggregate principal amount of its 5.125% senior secured fixed rate notes due 2032 (the “SSN Fixed Rate Notes” and, together wit

Stallergenes Greer Showcases Developments in Respiratory and Food Allergy Care at EAACI 202512.6.2025 08:00:00 CEST | Press release

Stallergenes Greer, a global leader in allergy therapeutics, will present insightful scientific developments at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, Glasgow (United Kingdom) June 13-16. The company will present 25 posters and host two scientific symposia during which six world-leading experts will share their insight on respiratory and food allergy: “Breath of change: redefining respiratory allergy care with remission in sight”: with environmental change impacting respiratory allergies, a new approach to disease management is necessary. Clinical remission is emerging as a relevant treatment goal for Type 2 allergies and allergen immunotherapy (AIT) has the potential to cater to this approach. “Myth busting in peanut allergy:separating fact from fiction”: misconceptions about food allergy management may influence treatment decisions, thus underscoring the vital role of patient-clinician communication. “We are enthusiastic to share how Stallergen

Samsung Bioepis Presents Long-Term Safety Data of EPYSQLI™ (Eculizumab) in PNH at the European Hematology Association (EHA) Congress 202512.6.2025 08:00:00 CEST | Press release

Long-term follow-up of EPYSQLI’s Phase 3 study showed consistency of safety data between the initial 52-week period and the extended treatment period up to 158 weeksNo new safety signals or fatal cases throughout the entire treatment period further supporting safety profile of EPYSQLI Samsung Bioepis Co., Ltd. (“Samsung Bioepis”) today presented the long-term safety data of EPYSQLI™ (eculizumab; SB12), a biosimilar to Soliris1, in paroxysmal nocturnal hemoglobinuria (PNH) at the European Hematology Association (EHA) Congress 2025 held at Milan, Italy from June 12 to 15. EPYSQLI was approved by the European Commission (EC) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) in May 2023 and March 2024, respectively2. The study assessed the long-term safety of EPYSQLI in PNH patients by evaluating the consistency of safety outcomes, particularly serious adverse events (SAEs) between the initial 52-week Phase 3 study period and the e

Andersen Consulting indgår samarbejdsaftale med DEX Ventures12.6.2025 05:48:00 CEST | Pressemeddelelse

Andersen Consulting styrker sit udbud af digital transformation med tilføjelsen af samarbejdspartneren DEX Ventures, der er et digitalt marketingbureau med speciale i vækststrategi og digital innovation. DEX Ventures tilbyder en omfattende portefølje af ydelser, der kombinerer strategi, performance marketing, design og digitale løsninger. Deres udbud omfatter vækstrådgivning for at støtte brandstrategier, effektivitet og kundeerhvervelsesprogrammer med brug af medier og analyseværktøjer, visuelle og UX-designtjenester samt udvikling af indhold og fællesskaber. Virksomheden leverer primært deres ydelser til multinationale selskaber og Fortune 500-virksomheder inden for forskellige brancher, herunder teknologi, olie og gas samt detailhandel. Alex Ooi, der er administrerende direktør for DEX Ventures, udtalte: "Vi er glade for at indgå et samarbejde med Andersen Consulting og drage fordel af organisationens globale platform og ekspertise for at kunne tilbyde endnu bedre støtte til kunder

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye